,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-02-10 23:04:00,"Sometimes mergers are necessary for survival, and at other times, they simply just make good old-fashioned sense.",0.03882632404565811,0.022390076890587807,0.938783586025238,neutral,0.016436247155070305
1,2017-02-10 23:04:00,"In either case, investors lucky enough to own stocks that do get bought out can turn a nice profit.",0.409267783164978,0.023957306519150734,0.5667749643325806,neutral,0.38531047105789185
2,2017-02-10 23:04:00,"We reached out to our contributors, and asked them to tell us what stocks they think could get bought.",0.16919034719467163,0.007194612640887499,0.8236150145530701,neutral,0.16199573874473572
3,2017-02-10 23:04:00,"They settled on Twitter (NYSE: TWTR ) , GoPro (NASDAQ: GPRO) , and Merrimack Pharmaceuticals (NASDAQ: MACK) .",0.051951754838228226,0.005513565614819527,0.9425347447395325,neutral,0.04643818736076355
4,2017-02-10 23:04:00,Read on to learn if these companies are worth owning in your portfolio.,0.06695626676082611,0.006007927469909191,0.9270358085632324,neutral,0.060948338359594345
5,2017-02-10 23:04:00,"Rich Smith (Twitter): Remember how last year, the internets were all a-twitter with rumors that Walt Disney -- or maybe Google , or perhaps salesforce.com -- was going to buy Twitter?",0.05126321688294411,0.12344001233577728,0.8252967000007629,neutral,-0.07217679917812347
6,2017-02-10 23:04:00,"It never actually happened, of course, but I think it might have happened -- and I think it still should happen.",0.17174533009529114,0.017412982881069183,0.8108416795730591,neutral,0.15433233976364136
7,2017-02-10 23:04:00,"Second only to Facebook in internet mindshare, Twitter is the stock success story that never quite made it.",0.2899697422981262,0.08728502690792084,0.6227452158927917,neutral,0.20268471539020538
8,2017-02-10 23:04:00,"Twitter went public more than three years ago at $26 per share, and almost immediately doubled in price before investors began to notice a ""giant sucking sound,"" which ultimately pulled down Twitter to its current price of $18.50.",0.052427101880311966,0.8056055903434753,0.14196734130382538,negative,-0.7531784772872925
9,2017-02-10 23:04:00,"You can blame Twitter's failure on any number of things: a lack of profits, single-digit revenue growth, or zero growth in its user base (as of last quarter).",0.020544832572340965,0.9000616669654846,0.0793934315443039,negative,-0.8795168399810791
10,2017-02-10 23:04:00,"At the same time, with 320 million monthly visitors to the site, Twitter remains a force to be reckoned with on the internet, and will only grow more important as President Trump uses it as his social-media trumpet.",0.2713318169116974,0.03756774589419365,0.6911004781723022,neutral,0.23376406729221344
11,2017-02-10 23:04:00,"Other fans of Twitter may tout its usefulness for keeping abreast of celebrity news, its deals with sports organizations, or its efforts in live-streaming.",0.11493327468633652,0.03252203390002251,0.8525446653366089,neutral,0.08241124451160431
12,2017-02-10 23:04:00,"But for me, the key is this: Today, anyone who wants to know what's going on in the White House, and even anyone who wants to oppose what's going on in the White House, needs to be on Twitter to stay informed.",0.059906262904405594,0.025385219603776932,0.9147084951400757,neutral,0.03452104330062866
13,2017-02-10 23:04:00,"This single fact makes Twitter one of the most important pieces of internet real estate out there today; if the company's current owners can't figure out how to make a profit off that, I'm certain there are other internet tycoons who have the egos to believe that they can do better.",0.39674386382102966,0.04021309316158295,0.5630430579185486,neutral,0.3565307855606079
14,2017-02-10 23:04:00,"Sooner or later, one of those guys is going to buy Twitter.",0.0618588887155056,0.022544827312231064,0.9155963063240051,neutral,0.039314061403274536
15,2017-02-10 23:04:00,I'm betting on sooner.,0.24099628627300262,0.01989697478711605,0.7391067147254944,neutral,0.22109931707382202
16,2017-02-10 23:04:00,"Tim Brugger (GoPro): Now that the Karma drone is back, at least in limited quantities in the U.S. (for now), some pundits have suggested that GoPro's future relies on consumers getting back on board now that its battery-latch issue has been resolved.",0.12215670943260193,0.4410100281238556,0.4368332326412201,negative,-0.31885331869125366
17,2017-02-10 23:04:00,"Unfortunately, it's not quite as simple as that.",0.03550846874713898,0.021528083831071854,0.9429634809494019,neutral,0.013980384916067123
18,2017-02-10 23:04:00,"As founder and CEO Nicholas Woodman noted in GoPro's recently announced fourth-quarter and 2016 annual results, its HERO5 Black camera was the best-selling digital ""imaging device"" in the country, along with select international markets, last quarter.",0.9258690476417542,0.02086303010582924,0.05326797813177109,positive,0.9050059914588928
19,2017-02-10 23:04:00,"And GoPro's mobile efforts, which include its Quik app, are picking up steam.",0.8333877921104431,0.01666565239429474,0.14994660019874573,positive,0.8167221546173096
20,2017-02-10 23:04:00,But the primary concern remains: GoPro simply doesn't have the product diversification it needs to weather an unexpected storm.,0.038572922348976135,0.8148512840270996,0.14657579362392426,negative,-0.7762783765792847
21,2017-02-10 23:04:00,"Woodman warned investors to not expect much in GoPro's fourth quarter, and the reason behind his trying to mute expectations is why GoPro is begging for a buyout.",0.08754687756299973,0.42292657494544983,0.48952654004096985,neutral,-0.3353796899318695
22,2017-02-10 23:04:00,"The problems started with the aforementioned Karma being recalled ahead of the all-important holiday shopping season, along with some manufacturing hiccups.",0.024458128958940506,0.9427743554115295,0.03276755288243294,negative,-0.9183162450790405
23,2017-02-10 23:04:00,"When one product miscue causes the poor results GoPro announced on Feb. 2, on the heels of an equally disappointing third quarter -- in which its revenue of $540.6 million was woefully short of the $574.5 million expected -- it's a scary proposition.",0.025474999099969864,0.9329029321670532,0.041622094810009,negative,-0.9074279069900513
24,2017-02-10 23:04:00,"However, a buyout by a company that could add GoPro's camera and drone to an already diversified product lineup: Now that would make sense.",0.6288561820983887,0.010980810038745403,0.36016303300857544,positive,0.6178753972053528
25,2017-02-10 23:04:00,"And the timing couldn't be better for a suitor, given GoPro's woeful 18% stock-price decline over the past year.",0.07553676515817642,0.8411273956298828,0.08333582431077957,negative,-0.7655906081199646
26,2017-02-10 23:04:00,"It's unlikely, but it could still happen

Todd Campbell (Merrimack Pharmaceuticals): Instead of buying Merrimack Pharmaceuticals lock, stock, and barrel, Ipsen (NASDAQOTH: IPSEY) bought Merrimack's only FDA-approved drug.",0.09900957345962524,0.011245228350162506,0.8897451758384705,neutral,0.08776434510946274
27,2017-02-10 23:04:00,"Ipsen's apparent unwillingness to acquire Merrimack outright casts doubt that any suitor will emerge for the company, especially now that it's sold its only commercial drug.",0.11234297603368759,0.6458762288093567,0.24178078770637512,negative,-0.5335332751274109
28,2017-02-10 23:04:00,But an acquisition is still possible.,0.16162456572055817,0.007912961766123772,0.8304625153541565,neutral,0.15371160209178925
29,2017-02-10 23:04:00,"Weighed down by a heavy debt load and commercialization expenses associated with its pancreatic cancer drug Onivyde, Merrimack announced a massive layoff last fall.",0.020535415038466454,0.9669017195701599,0.012562915682792664,negative,-0.9463663101196289
30,2017-02-10 23:04:00,"The layoff gave the company some wiggle room, but it wasn't enough, so the board cut a deal to sell Onivyde to Ipsen for $575 million up front, plus promises of up to $450 million in milestone payments.",0.036077991127967834,0.9213142991065979,0.04260765016078949,negative,-0.8852363228797913
31,2017-02-10 23:04:00,"The company plans to return $200 million of the up-front money to investors as a special dividend, and plans to retire $175 million in long-term debt.",0.030229592695832253,0.009372192434966564,0.960398256778717,neutral,0.020857401192188263
32,2017-02-10 23:04:00,Management will also invest $125 million of the windfall back into its clinical-stage drug pipeline.,0.5151389241218567,0.010432776995003223,0.47442832589149475,positive,0.5047061443328857
33,2017-02-10 23:04:00,"This deal gives Merrimack Pharmaceuticals a cash runway that stretches into 2019; hopefully, that will be enough time for management to prove that the remaining drugs in its pipeline are worthwhile.",0.9268409013748169,0.01470381673425436,0.058455247431993484,positive,0.9121370911598206
34,2017-02-10 23:04:00,"Those drugs include MM-121, which is being evaluated in non-small cell lung cancer, MM-141, which is being studied in metastatic pancreatic cancer, and MM-310, a preclinical drug that's expected to enter phase 1 trials this year.",0.10755352675914764,0.005151104182004929,0.8872953057289124,neutral,0.10240241885185242
35,2017-02-10 23:04:00,"Undeniably, the company will be in better financial shape than it's been in years, once this deal closes.",0.9327652454376221,0.016871778294444084,0.050363004207611084,positive,0.9158934950828552
36,2017-02-10 23:04:00,But trial uncertainty and ongoing expenses could make Merrimack Pharmaceuticals open to entertaining offers from a suitor.,0.20765820145606995,0.37846657633781433,0.4138752520084381,neutral,-0.17080837488174438
37,2017-02-10 23:04:00,"If not, it might at least be willing to cozy up with a deep-pocketed biopharma on one or more of its remaining drugs.",0.78408282995224,0.023645900189876556,0.19227126240730286,positive,0.7604369521141052
38,2017-02-10 23:04:00,"10 stocks we like better than Merrimack Pharmaceuticals

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.13539165258407593,0.032364096492528915,0.8322442173957825,neutral,0.10302755236625671
39,2017-02-10 23:04:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has tripled the market.",0.46925464272499084,0.07301506400108337,0.4577302634716034,positive,0.39623957872390747
40,2017-02-10 23:04:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Merrimack Pharmaceuticals wasn't one of them!",0.20117366313934326,0.013235488906502724,0.7855908274650574,neutral,0.1879381686449051
41,2017-02-10 23:04:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
42,2017-02-10 23:04:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
43,2017-02-10 23:04:00,"Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors.",0.022025013342499733,0.015809211879968643,0.9621658325195312,neutral,0.00621580146253109
44,2017-02-10 23:04:00,Rich Smith owns shares of Alphabet (C shares).,0.014433884993195534,0.009999418631196022,0.9755666851997375,neutral,0.004434466361999512
45,2017-02-10 23:04:00,Tim Brugger owns shares of Walt Disney.,0.01757930964231491,0.011252566240727901,0.9711681008338928,neutral,0.006326743401587009
46,2017-02-10 23:04:00,"Todd Campbell owns shares of Facebook, Merrimack Pharmaceuticals, Salesforce.com, and Twitter.",0.01784566044807434,0.012012582272291183,0.9701417088508606,neutral,0.005833078175783157
47,2017-02-10 23:04:00,"The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), Facebook, GoPro, Twitter, and Walt Disney.",0.019506795331835747,0.010491807013750076,0.9700013995170593,neutral,0.00901498831808567
48,2017-02-10 23:04:00,The Motley Fool has the following options: short January 2019 $12 calls on GoPro and long January 2019 $12 puts on GoPro.,0.012741689570248127,0.019597064703702927,0.9676612615585327,neutral,-0.0068553751334548
49,2017-02-10 23:04:00,The Motley Fool recommends Salesforce.com.,0.033904511481523514,0.0381915383040905,0.927903950214386,neutral,-0.004287026822566986
50,2017-02-10 23:04:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
51,2017-02-10 23:04:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
